A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C

Autor: Cevik, M., Katsarolis, I., Singh, G.J., Nelson, M.
Zdroj: In Journal of Infection August 2014 69(2):190-193
Databáze: ScienceDirect